"Take a Closer Look", page-523

At $6.73 it's down from $16 two years ago and down from $23 four years ago
In perspective they only have 28.5m shares outstanding
Lost $48m last year
Has about $25m in cash
If we had that amount of stock outstanding we'd be sitting around $2.86
Also they have a larger institutional holding which propels and maintains such a market cap feeding clients based in the US mainly as what they'd sell as the only or main HSV play
Nice try to downramp and playing the minds of newbies imo
One also must remember the Us market is a lot different to our market in terms of funds, institutional investing and mindset
And a stock price is a different beast compared to the actual company
They also ran a larger trial compared to ours
Cheers